OSALEUKIN Trademark

Trademark Overview

On Friday, December 15, 2006, a trademark application was filed for OSALEUKIN with the United States Patent and Trademark Office. The USPTO has given the OSALEUKIN trademark a serial number of 79034631. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, December 15, 2016. This trademark is owned by TMRC Co., Ltd.. The OSALEUKIN trademark is filed in the Pharmaceutical Products category with the following description:

Anticancer drugs; antitumor drugs; antineoplastic drugs; drugs for medical purposes, namely, Retinoic acid Receptor agonist for the treatment of autoimmune/inflammatory diseases, vascular diseases, neurodegenerative diseases, psoriasis, palmoplantar pustulosis, wrinkles, and severe acne
osaleukin

General Information

Serial Number79034631
Word MarkOSALEUKIN
Filing DateFriday, December 15, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, December 15, 2016
Registration Number3395110
Registration DateTuesday, March 11, 2008
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 25, 2007

Trademark Statements

Goods and ServicesAnticancer drugs; antitumor drugs; antineoplastic drugs; drugs for medical purposes, namely, Retinoic acid Receptor agonist for the treatment of autoimmune/inflammatory diseases, vascular diseases, neurodegenerative diseases, psoriasis, palmoplantar pustulosis, wrinkles, and severe acne

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 17, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTMRC Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameTMRC Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameTMRC Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, July 7, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, July 7, 2017DEATH OF INTERNATIONAL REGISTRATION
Friday, September 11, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, August 14, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, August 14, 2015INVALIDATION PROCESSED
Wednesday, June 17, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 20, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 17, 2014CANCELLED SECTION 71
Friday, February 12, 2010FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 12, 2008FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 12, 2008FINAL DISPOSITION PROCESSED
Wednesday, June 11, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 11, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, December 25, 2007PUBLISHED FOR OPPOSITION
Wednesday, December 5, 2007NOTICE OF PUBLICATION
Friday, November 16, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 15, 2007ASSIGNED TO LIE
Friday, October 12, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 11, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 11, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 11, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 3, 2007REFUSAL PROCESSED BY IB
Friday, April 13, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 13, 2007REFUSAL PROCESSED BY MPU
Thursday, April 12, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, April 11, 2007NON-FINAL ACTION WRITTEN
Tuesday, April 10, 2007ASSIGNED TO EXAMINER
Thursday, March 8, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, March 8, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

osaleukin drugs diseases neurodegenerative vascular inflammatory psoriasis pustulosis acne severe wrinkles